CIC
SYNH

Chase Investment Counsel’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Chase Investment Counsel’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-9,130
Closed -$543K – 122
2019
Q4 		$543K Buy
9,130
+1,050
+13% +$56.4K 0.28% 67
2019
Q3 		$429K Buy
+8,080
New +$415K 0.22% 75

Other funds holding SYNH

AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
THLTP
Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Chase Investment Counsel's SYNH Position: Q1 2020 in Review

Chase Investment Counsel sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2020, closing a stake of 9,130 shares — an estimated $543K sold.

Chase Investment Counsel first reported a position in SYNH in Q3 2019 and held it in 2 quarters. The position peaked at $543K in Q4 2019. 260 funds tracked by Wall St. Rank hold SYNH as of Q1 2020.

  • Chase Investment Counsel reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2020 after selling out during the quarter.
  • Chase Investment Counsel sold 9,130 Syneos Health, Inc. Class A Common Stock shares in Q1 2020, an estimated $543K.
  • Chase Investment Counsel first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2019 and held it in 2 quarters.
  • Chase Investment Counsel's Syneos Health, Inc. Class A Common Stock position peaked at $543K in Q4 2019.
  • 260 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2020.

Based on Chase Investment Counsel's 13F filing for Q1 2020, filed 8 May 2020.